An international survey of classification and treatment choices for group D retinoblastoma
Author(s) -
Christina Scelfo,
Jasmine H. Francis,
Vikas Khetan,
Thomas M. Jenkins,
Brian P. Marr,
David H. Abramson,
Carol L. Shields,
Jacob Pe’er,
Francis L. Munier,
Jesse L. Berry,
J. William Harbour,
А.А. Yarovoy,
Evandro Lucena,
Timothy G. Murray,
Pooja Bhagia,
Evelyn A. Paysse,
Samuray Tuncer,
Guillermo Chantada,
Annette C. Moll,
Tatiana L. Ushakova,
David A. Plager,
Islamov Ziyovuddin,
Carlos A. Leal,
Miguel A. Materin,
Xun-Da Ji,
José Wilson Cursino,
Rodrigo A. Polania,
Hayyam Kíratlí,
Charlotta AllEricsson,
Rejin Kebudi,
Santosh G Honavar,
Vicktoria VishnevskiaDai,
Sidnel Epelman,
Anthony B. Daniels,
Jeanie D. Ling,
Fousseyni Traoré,
Marco A. RamírezOrtiz
Publication year - 2017
Publication title -
international journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.634
H-Index - 29
eISSN - 2227-4898
pISSN - 2222-3959
DOI - 10.18240/ijo.2017.06.20
Subject(s) - enucleation , medicine , retinoblastoma , globe , cog , ophthalmology , surgery , artificial intelligence , chemistry , computer science , gene , biochemistry
To determine which IIRC scheme was used by retinoblastoma centers worldwide and the percentage of D eyes treated primarily with enucleation versus globe salvaging therapies as well as to correlate trends in treatment choice to IIRC version used and geographic region.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom